In case you’re looking at these medications, or perhaps switching to at least one from the opposite, Dr. Jaisinghani says to talk to knowledgeable.In October 2024, Novo Nordisk released a examine on scientific journal Character about a novel glucose-delicate insulin NNC2215 that could lower the potential risk of hypoglycemia in animal models.[six